title: Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients.
authors.affiliation: Hôpital Marie Lannelongue, Universite Paris-Sud, France.
authors.forename: J
authors.initials: J
authors.lastname: Cerrina
authors.forename: E
authors.initials: E
authors.lastname: Bavoux
authors.forename: F
authors.initials: F
authors.lastname: Le Roy Ladurie
authors.forename: P
authors.initials: P
authors.lastname: Herve
authors.forename: D
authors.initials: D
authors.lastname: Lafont
authors.forename: G
authors.initials: G
authors.lastname: Simonneau
authors.forename: P
authors.initials: P
authors.lastname: Dartevelle
mesh_terms: D000293:Adolescent; D000328:Adult; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D016041:Heart-Lung Transplantation / Q000379:methods*; D006801:Humans; D016040:Lung Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D015774:Ganciclovir